| Unit 1 Fundamental Foundations of Practice |
|
1 | (162) |
|
1 Risk Management and Quality Patient Management |
|
|
3 | (40) |
|
Legal and Ethical Issues in Infusion Therapy |
|
|
6 | (8) |
|
Risk Management and Risk Assessment |
|
|
14 | (5) |
|
Developing and Participating in Product Evaluation |
|
|
19 | (2) |
|
Performance Improvement and Quality Patient Management |
|
|
21 | (6) |
|
Developing Nursing Competency Standards |
|
|
27 | (3) |
|
|
|
30 | (13) |
|
2 Infection Control Measures |
|
|
43 | (38) |
|
|
|
46 | (4) |
|
Basic Principles of Epidemiology |
|
|
50 | (1) |
|
|
|
51 | (4) |
|
Infusion-Related Infections |
|
|
55 | (11) |
|
Strategies for Preventing/Treating Infection |
|
|
66 | (15) |
|
3 Fundamentals of Fluid Balance |
|
|
81 | (29) |
|
|
|
83 | (2) |
|
|
|
85 | (1) |
|
|
|
86 | (5) |
|
|
|
91 | (3) |
|
|
|
94 | (4) |
|
|
|
98 | (12) |
|
4 Fundamentals of Electrolyte Balance |
|
|
110 | (53) |
|
Basic Principles of Electrolyte Balance |
|
|
112 | (2) |
|
|
|
114 | (5) |
|
|
|
119 | (7) |
|
|
|
126 | (6) |
|
|
|
132 | (5) |
|
|
|
137 | (3) |
|
|
|
140 | (3) |
|
|
|
143 | (4) |
|
Major Acid-Base Imbalances |
|
|
147 | (1) |
|
Metabolic Acid-Base Imbalance |
|
|
147 | (4) |
|
Respiratory Acid-Base Imbalance |
|
|
151 | (12) |
| Unit 2 Basic Infusion Practice |
|
163 | (284) |
|
|
|
165 | (32) |
|
Rationales and Objectives of Parenteral Therapy |
|
|
167 | (3) |
|
Key Elements in Parenteral Solutions |
|
|
170 | (3) |
|
Osmolarity of Parenteral Solutions |
|
|
173 | (2) |
|
Types of Parenteral Solutions |
|
|
175 | (22) |
|
|
|
197 | (60) |
|
Infusion Therapy Equipment |
|
|
199 | (1) |
|
Infusion Delivery Systems |
|
|
200 | (6) |
|
|
|
206 | (7) |
|
Accessory Devices for Administration Sets |
|
|
213 | (11) |
|
Peripheral Infusion Devices |
|
|
224 | (6) |
|
|
|
230 | (5) |
|
Infusion Regulation Devices |
|
|
235 | (22) |
|
7 Techniques for Peripheral Intravenous Therapy |
|
|
257 | (66) |
|
Anatomy and Physiology Related to I.V. Practice |
|
|
259 | (4) |
|
Approaches to Venipuncture |
|
|
263 | (25) |
|
Discontinuation of the I.V. Cannula |
|
|
288 | (1) |
|
Intermittent Infusion Devices |
|
|
289 | (2) |
|
|
|
291 | (4) |
|
Calculating the I.V. Rate |
|
|
295 | (28) |
|
|
|
323 | (33) |
|
Introduction to Phlebotomy |
|
|
325 | (1) |
|
Steps in Collection of Blood Specimens |
|
|
326 | (14) |
|
|
|
340 | (16) |
|
9 Complications of Intravenous Therapy |
|
|
356 | (50) |
|
Complications of I.V. Therapy |
|
|
358 | (1) |
|
|
|
358 | (28) |
|
|
|
386 | (20) |
|
10 Special Considerations Related to Intravenous Therapy: The Pediatric and Geriatric Populations |
|
|
406 | (41) |
|
|
|
408 | (20) |
|
|
|
428 | (6) |
|
|
|
434 | (13) |
| Unit 3 Advanced Infusion Practice |
|
447 | (320) |
|
11 Administration of Intravenous Medications |
|
|
449 | (53) |
|
Principles of Intravenous Medication Administration |
|
|
451 | (4) |
|
|
|
455 | (4) |
|
|
|
459 | (2) |
|
Intravenous Medication Administration |
|
|
461 | (7) |
|
Continuous Subcutaneous Medication Administration |
|
|
468 | (3) |
|
Intraperitoneal Medication Administration |
|
|
471 | (1) |
|
Intraosseous Medication Administration |
|
|
471 | (1) |
|
Intraventricular Medication Administration |
|
|
471 | (1) |
|
Intra-arterial Medication Administration |
|
|
472 | (1) |
|
|
|
472 | (3) |
|
Epidural and Intrathecal Medication Administration |
|
|
475 | (12) |
|
Special Drug Administration Considerations |
|
|
487 | (15) |
|
|
|
502 | (71) |
|
Julie Eddins, RN, MSN, CRNI |
|
|
|
Anatomy of the Vascular System |
|
|
505 | (3) |
|
Choosing the Venous Access Device |
|
|
508 | (9) |
|
Preventing Catheter-Related Infections |
|
|
517 | (1) |
|
Short-Term Access Devices |
|
|
518 | (22) |
|
|
|
540 | (16) |
|
Management of Occluded Central Venous Access Devices |
|
|
556 | (7) |
|
Pediatric Central Venous Access |
|
|
563 | (10) |
|
|
|
573 | (74) |
|
|
|
576 | (7) |
|
Blood Donor Collection Methods |
|
|
583 | (6) |
|
|
|
589 | (14) |
|
|
|
603 | (2) |
|
|
|
605 | (1) |
|
|
|
605 | (3) |
|
Administration of Blood Components |
|
|
608 | (12) |
|
Complications Associated with Blood Component Therapy |
|
|
620 | (27) |
|
14 Antineoplastic Therapy |
|
|
647 | (61) |
|
Pamela Hockett, RN, MSN, CNS, OCN |
|
|
|
The Role of the Clinician |
|
|
650 | (2) |
|
Guidelines for Handling Hazardous Drugs (HDs) |
|
|
652 | (1) |
|
|
|
653 | (2) |
|
|
|
655 | (2) |
|
|
|
657 | (15) |
|
Common Side Effects of Chemotherapy |
|
|
672 | (16) |
|
Chemotherapy: Routes of Administration |
|
|
688 | (20) |
|
|
|
708 | (59) |
|
|
|
710 | (1) |
|
|
|
711 | (2) |
|
|
|
713 | (7) |
|
|
|
720 | (10) |
|
Nutritional Support Candidates |
|
|
730 | (37) |
| APPENDIX A: Summary of Recommended Procedures for Maintenance of Intravascular Catheters, Administration Sets, and Parenteral Fluids |
|
767 | (4) |
| APPENDIX B: Competency SkillChecks |
|
771 | (18) |
| INDEX |
|
789 | |
Shopping Cart
